Jean-Frederic Viret is CFO at Coherus BioSciences, Inc. (CHRS). They have made 22 open-market trades across 1 company since 2016, most recently 2024-04-05.
CIK 0001427569
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CHRS | SELL | 2021-02-01 | 2021-02-03 | $21.55 | $319K | +0.8% | -8.6% | -14.6% |
| CHRS | SELL | 2021-01-25 | 2021-01-27 | $19.95 | $921K | -7.1% | -23.3% | -31.1% |
| CHRS | SELL · 10b5-1 | 2020-11-17 | 2020-11-19 | $17.49 | $35K | +5.8% | -3.3% | -2.8% |
| CHRS | SELL | 2020-10-14 | 2020-10-16 | $19.00 | $117K | -5.5% | -0.4% | -0.7% |
| CHRS | SELL · 10b5-1 | 2020-05-20 | 2020-05-22 | $17.66 | $23K | +5.8% | -0.6% | +9.8% |
| CHRS | SELL | 2020-02-19 | 2020-02-21 | $22.33 | $141K | -5.8% | -34.8% | -25.6% |
| CHRS | SELL | 2020-01-15 | 2020-01-17 | $19.85 | $251K | -3.5% | +16.0% | -21.5% |
| CHRS | SELL | 2019-11-20 | 2019-11-22 | $19.59 | $124K | -6.3% | -2.7% | +20.0% |
| CHRS | SELL | 2019-11-18 | 2019-11-20 | $18.88 | $118K | -9.3% | -4.8% | +14.9% |
| CHRS | SELL · 10b5-1 | 2019-10-18 | 2019-10-22 | $19.02 | $26K | -4.9% | -0.4% | +3.8% |
| CHRS | SELL | 2019-10-16 | 2019-10-18 | $19.00 | $60K | -10.0% | -1.2% | +2.3% |
| CHRS | SELL · 10b5-1 | 2019-09-23 | 2019-09-25 | $21.78 | $16K | -5.0% | -25.0% | -15.7% |
| CHRS | SELL | 2019-09-18 | 2019-09-20 | $20.44 | $129K | -7.7% | -11.9% | -17.3% |
| CHRS | SELL | 2019-08-21 | 2019-08-23 | $21.73 | $269K | -6.4% | -5.0% | -17.8% |
| CHRS | SELL | 2019-08-19 | 2019-08-21 | $19.04 | $57K | -0.4% | -1.2% | -10.9% |
| CHRS | SELL | 2019-06-19 | 2019-06-20 | $20.32 | $62K | +5.7% | -21.5% | -5.3% |
| CHRS | SELL | 2019-06-18 | 2019-06-20 | $19.31 | $58K | +5.7% | -21.5% | -5.3% |
| CHRS | SELL | 2019-06-18 | 2019-06-20 | $19.84 | $256K | +5.7% | -21.5% | -5.3% |
| CHRS | SELL | 2019-03-20 | 2019-03-22 | $14.92 | $45K | -3.2% | +1.9% | +51.7% |
| CHRS | SELL | 2018-07-23 | 2018-07-25 | $18.56 | $345K | -0.3% | +2.4% | -34.5% |
| CHRS | SELL | 2017-01-25 | 2017-01-27 | $27.00 | $105K | -14.6% | -17.2% | -28.0% |
| CHRS | SELL | 2016-12-16 | 2016-12-20 | $28.30 | $110K | +0.5% | -6.3% | -14.9% |
| CHRS | SELL | 2016-11-18 | 2016-11-22 | $28.19 | $110K | +4.5% | +3.9% | -15.8% |
| CHRS | SELL | 2016-10-21 | 2016-10-25 | $30.62 | $119K | -7.4% | -7.7% | -13.8% |
| CHRS | SELL | 2016-10-21 | 2016-10-25 | $30.62 | $119K | -7.4% | -7.7% | -13.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.